CHMP Recommends 13 New Drugs for Approval, Including Two Orphan Meds

The EMA’s Committee for Medicinal Products for Human Use (CHMP) flagged 13 medicines for approval at its April meeting, including two orphan medications and a biosimilar.
Source: Drug Industry Daily